Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

HER-family ligands promote acquired resistance to trastuzumab in gastric cancer.

Sampera A, Sánchez-Martín FJ, Arpí O, Visa L, Iglesias M, Menéndez S, Gaye É, Dalmases A, Clavé S, Gelabert-Baldrich M, Poulsen TT, Kragh M, Bellosillo B, Albanell J, Rovira A, Montagut C.

Mol Cancer Ther. 2019 Sep 4. pii: molcanther.0455.2019. doi: 10.1158/1535-7163.MCT-19-0455. [Epub ahead of print]

PMID:
31484705
2.

RhoBTB1 interacts with ROCKs and inhibits invasion.

Haga RB, Garg R, Collu F, Borda D'Agua B, Menéndez ST, Colomba A, Fraternali F, Ridley AJ.

Biochem J. 2019 Sep 13;476(17):2499-2514. doi: 10.1042/BCJ20190203.

PMID:
31431478
3.

The Role of Parenting Styles on Behavior Problem Profiles of Adolescents.

Lorence B, Hidalgo V, Pérez-Padilla J, Menéndez S.

Int J Environ Res Public Health. 2019 Aug 2;16(15). pii: E2767. doi: 10.3390/ijerph16152767.

4.

"The big sleep: Elucidating the sequence of events in the first hours of death to determine the postmortem interval".

Martínez PN, Menéndez ST, Villaronga MLÁ, Ubelaker DH, García-Pedrero JM, C Zapico S.

Sci Justice. 2019 Jul;59(4):418-424. doi: 10.1016/j.scijus.2019.03.001. Epub 2019 Mar 5.

PMID:
31256813
5.

Novel Oral mTORC1/2 Inhibitor TAK-228 Has Synergistic Antitumor Effects When Combined with Paclitaxel or PI3Kα Inhibitor TAK-117 in Preclinical Bladder Cancer Models.

Hernández-Prat A, Rodriguez-Vida A, Juanpere-Rodero N, Arpi O, Menéndez S, Soria-Jiménez L, Martínez A, Iarchouk N, Rojo F, Albanell J, Brake R, Rovira A, Bellmunt J.

Mol Cancer Res. 2019 Sep;17(9):1931-1944. doi: 10.1158/1541-7786.MCR-18-0923. Epub 2019 Jun 3.

PMID:
31160383
6.

New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth.

Rey V, Menendez ST, Estupiñan O, Rodriguez A, Santos L, Tornin J, Martinez-Cruzado L, Castillo D, Ordoñez GR, Costilla S, Alvarez-Fernandez C, Astudillo A, Braña A, Rodriguez R.

J Clin Med. 2019 Apr 4;8(4). pii: E455. doi: 10.3390/jcm8040455.

7.

The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors.

Tormo E, Ballester S, Adam-Artigues A, Burgués O, Alonso E, Bermejo B, Menéndez S, Zazo S, Madoz-Gúrpide J, Rovira A, Albanell J, Rojo F, Lluch A, Eroles P.

Sci Rep. 2019 Mar 29;9(1):5316. doi: 10.1038/s41598-019-41472-y.

8.

The Novel Role of SOX2 as an Early Predictor of Cancer Risk in Patients with Laryngeal Precancerous Lesions.

Granda-Díaz R, Menéndez ST, Pedregal Mallo D, Hermida-Prado F, Rodríguez R, Suárez-Fernández L, Vallina A, Sánchez-Canteli M, Rodríguez A, Fernández-García MS, Rodrigo JP, García-Pedrero JM.

Cancers (Basel). 2019 Mar 1;11(3). pii: E286. doi: 10.3390/cancers11030286.

9.

Biochar reduces the efficiency of nitrification inhibitor 3,4-dimethylpyrazole phosphate (DMPP) mitigating N2O emissions.

Fuertes-Mendizábal T, Huérfano X, Vega-Mas I, Torralbo F, Menéndez S, Ippolito JA, Kammann C, Wrage-Mönnig N, Cayuela ML, Borchard N, Spokas K, Novak J, González-Moro MB, González-Murua C, Estavillo JM.

Sci Rep. 2019 Feb 20;9(1):2346. doi: 10.1038/s41598-019-38697-2.

10.

[Psychological well-being in non-dependent active elderly individuals and its relationship with self-esteem and self-efficacy].

Mesa-Fernández M, Pérez-Padilla J, Nunes C, Menéndez S.

Cien Saude Colet. 2019 Jan;24(1):115-124. doi: 10.1590/1413-81232018241.35302016. Spanish.

11.

The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas.

Estupiñan O, Santos L, Rodriguez A, Fernandez-Nevado L, Costales P, Perez-Escuredo J, Hermosilla MA, Oro P, Rey V, Tornin J, Allonca E, Fernandez-Garcia MT, Alvarez-Fernandez C, Braña A, Astudillo A, Menendez ST, Moris F, Rodriguez R.

Int J Cancer. 2019 Jul 1;145(1):254-266. doi: 10.1002/ijc.32081. Epub 2019 Jan 14.

PMID:
30575954
12.

Factor Analysis of EMA-Scale on Adolescent Adjustment From a Developmental Perspective: A Short Form.

Jiménez L, Menéndez S, Hidalgo V.

Front Psychol. 2018 Dec 3;9:2406. doi: 10.3389/fpsyg.2018.02406. eCollection 2018.

13.

NK Cell Infiltrates and HLA Class I Expression in Primary HER2+ Breast Cancer Predict and Uncouple Pathological Response and Disease-free Survival.

Muntasell A, Rojo F, Servitja S, Rubio-Perez C, Cabo M, Tamborero D, Costa-García M, Martínez-Garcia M, Menéndez S, Vazquez I, Lluch A, Gonzalez-Perez A, Rovira A, López-Botet M, Albanell J.

Clin Cancer Res. 2019 Mar 1;25(5):1535-1545. doi: 10.1158/1078-0432.CCR-18-2365. Epub 2018 Dec 6.

PMID:
30523021
14.

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.

Hermida-Prado F, Menéndez ST, Albornoz-Afanasiev P, Granda-Diaz R, Álvarez-Teijeiro S, Villaronga MÁ, Allonca E, Alonso-Durán L, León X, Alemany L, Mena M, Del-Rio-Ibisate N, Astudillo A, Rodríguez R, Rodrigo JP, García-Pedrero JM.

J Clin Med. 2018 Dec 1;7(12). pii: E501. doi: 10.3390/jcm7120501.

15.

IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML.

Lopez-Millan B, Diaz de la Guardia R, Roca-Ho H, Anguita E, Islam ABMMK, Romero-Moya D, Prieto C, Gutierrez-Agüera F, Bejarano-Garcia JA, Perez-Simon JA, Costales P, Rovira M, Marín P, Menendez S, Iglesias M, Fuster JL, Urbano-Ispizua A, Anjos-Afonso F, Bueno C, Menendez P.

Oncoimmunology. 2018 Jul 26;7(9):e1477460. doi: 10.1080/2162402X.2018.1477460. eCollection 2018.

16.

Role of Activator Protein-1 Complex on the Phenotype of Human Osteosarcomas Generated from Mesenchymal Stem Cells.

Gambera S, Abarrategi A, Rodríguez-Milla MA, Mulero F, Menéndez ST, Rodriguez R, Navarro S, García-Castro J.

Stem Cells. 2018 Oct;36(10):1487-1500. doi: 10.1002/stem.2869. Epub 2018 Aug 11.

PMID:
30001480
17.

Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.

Villaronga MÁ, Hermida-Prado F, Granda-Díaz R, Menéndez ST, Álvarez-Teijeiro S, Quer M, Vilaseca I, Allonca E, Garzón-Arango M, Sanz-Moreno V, Astudillo A, Rodrigo JP, García-Pedrero JM.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):805-813. doi: 10.1158/1055-9965.EPI-17-1082. Epub 2018 Apr 13.

18.

Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma.

Gallardo F, Bertran J, López-Arribillaga E, González J, Menéndez S, Sánchez I, Colomo L, Iglesias M, Garrido M, Santamaría-Babí LF, Torres F, Pujol RM, Bigas A, Espinosa L.

Leukemia. 2018 Oct;32(10):2211-2223. doi: 10.1038/s41375-018-0066-4. Epub 2018 Feb 22.

19.

Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Rodrigo JP, Manterola L, de Villalaín L, de Vicente JC, Alonso-Durán L, Fernández MP, Lawrie CH, García-Pedrero JM.

Sci Rep. 2017 Dec 19;7(1):17785. doi: 10.1038/s41598-017-18138-8.

20.

FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway.

Tornin J, Hermida-Prado F, Padda RS, Gonzalez MV, Alvarez-Fernandez C, Rey V, Martinez-Cruzado L, Estupiñan O, Menendez ST, Fernandez-Nevado L, Astudillo A, Rodrigo JP, Lucien F, Kim Y, Leong HS, Garcia-Pedrero JM, Rodriguez R.

Neoplasia. 2018 Jan;20(1):44-56. doi: 10.1016/j.neo.2017.11.004. Epub 2017 Nov 28.

21.

Characteristics of Emergency Medicine Residency Programs in Colombia.

Patiño A, Alcalde V, Gutierrez C, Romero MG, Carrillo AM, Vargas LE, Vallejo CE, Zarama V, Mora Rodriguez JL, Bustos Y, Granada J, Aguiar LG, Menéndez S, Cohen JI, Saavedra MA, Rodriguez JM, Roldan T, Arbelaez C.

West J Emerg Med. 2017 Oct;18(6):1120-1127. doi: 10.5811/westjem.2017.7.34668. Epub 2017 Sep 18.

22.

Dimethyl pyrazol-based nitrification inhibitors effect on nitrifying and denitrifying bacteria to mitigate N2O emission.

Torralbo F, Menéndez S, Barrena I, Estavillo JM, Marino D, González-Murua C.

Sci Rep. 2017 Oct 23;7(1):13810. doi: 10.1038/s41598-017-14225-y.

23.

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.

Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, Allonca E, Pedregal Mallo D, Astudillo A, García-Pedrero JM.

Sci Rep. 2017 Sep 11;7(1):11110. doi: 10.1038/s41598-017-11709-9.

24.

Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer.

Sabbaghi M, Gil-Gómez G, Guardia C, Servitja S, Arpí O, García-Alonso S, Menendez S, Arumi-Uria M, Serrano L, Salido M, Muntasell A, Martínez-García M, Zazo S, Chamizo C, González-Alonso P, Madoz-Gúrpide J, Eroles P, Arribas J, Tusquets I, Lluch A, Pandiella A, Rojo F, Rovira A, Albanell J.

Clin Cancer Res. 2017 Nov 15;23(22):7006-7019. doi: 10.1158/1078-0432.CCR-17-0696. Epub 2017 Aug 18.

25.

CD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.

Clavé S, Pijuan L, Casadevall D, Taus Á, Gimeno J, Hernández-Llodrà S, Rodríguez-Rivera M, Lorenzo M, Menéndez S, Albanell J, Espinet B, Arriola E, Salido M.

Histopathology. 2018 Jan;72(2):259-269. doi: 10.1111/his.13339. Epub 2017 Oct 27.

PMID:
28795418
26.

Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Pena-Alonso E, Rodrigo JP, Morgan RO, Granda-Díaz R, Salom C, Fernandez MP, García-Pedrero JM.

Sci Rep. 2017 Jul 28;7(1):6790. doi: 10.1038/s41598-017-07169-w.

27.

Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.

Casadevall D, Clavé S, Taus Á, Hardy-Werbin M, Rocha P, Lorenzo M, Menéndez S, Salido M, Albanell J, Pijuan L, Arriola E.

Clin Lung Cancer. 2017 Nov;18(6):682-691.e5. doi: 10.1016/j.cllc.2017.04.014. Epub 2017 May 4.

PMID:
28549836
28.

Sheep as a Potential Source of Bovine TB: Epidemiology, Pathology and Evaluation of Diagnostic Techniques.

Muñoz-Mendoza M, Romero B, Del Cerro A, Gortázar C, García-Marín JF, Menéndez S, Mourelo J, de Juan L, Sáez JL, Delahay RJ, Balseiro A.

Transbound Emerg Dis. 2016 Dec;63(6):635-646. doi: 10.1111/tbed.12325. Epub 2015 Jan 19.

PMID:
25644146
29.

Human mitochondrial DNA and nuclear DNA isolation from food bite marks.

C Zapico S, Menéndez ST.

Arch Oral Biol. 2016 Oct;70:67-72. doi: 10.1016/j.archoralbio.2016.06.004. Epub 2016 Jun 8.

PMID:
27341457
30.

Synthesis and DFT Study of a Diphenylsilanone-Bridged Dimolybdenum Complex.

Alvarez MA, García ME, García-Vivó D, Menéndez S, Ruiz MA.

Chemistry. 2016 Jun 20;22(26):8763-7. doi: 10.1002/chem.201601598. Epub 2016 May 13.

PMID:
27124667
31.

HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.

Menéndez ST, Villaronga MÁ, Rodrigo JP, Álvarez-Teijeiro S, Urdinguio RG, Fraga MF, Suárez C, García-Pedrero JM.

Sci Rep. 2016 Jan 20;6:19666. doi: 10.1038/srep19666.

32.

ROS1 copy number alterations are frequent in non-small cell lung cancer.

Clavé S, Gimeno J, Muñoz-Mármol AM, Vidal J, Reguart N, Carcereny E, Pijuan L, Menéndez S, Taus Á, Mate JL, Serrano S, Albanell J, Espinet B, Arriola E, Salido M.

Oncotarget. 2016 Feb 16;7(7):8019-28. doi: 10.18632/oncotarget.6921.

33.

Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.

Rodrigo JP, Menéndez ST, Hermida-Prado F, Álvarez-Teijeiro S, Villaronga MÁ, Alonso-Durán L, Vallina A, Martínez-Camblor P, Astudillo A, Suárez C, María García-Pedrero J.

Sci Rep. 2015 Oct 26;5:15698. doi: 10.1038/srep15698.

34.

Angiopoietin-2 is a negative prognostic marker in small cell lung cancer.

Cañadas I, Taus Á, Villanueva X, Arpí O, Pijuan L, Rodríguez Y, Menéndez S, Mojal S, Rojo F, Albanell J, Rovira A, Arriola E.

Lung Cancer. 2015 Nov;90(2):302-6. doi: 10.1016/j.lungcan.2015.09.023. Epub 2015 Sep 26.

PMID:
26428740
35.

Validity of the Parenting Stress Index Short Form in a Sample of At-Risk Mothers.

Pérez-Padilla J, Menéndez S, Lozano O.

Eval Rev. 2015 Aug;39(4):428-46. doi: 10.1177/0193841X15600859. Epub 2015 Aug 21.

PMID:
26297624
36.

Reprogramming Roadblocks Are System Dependent.

Chantzoura E, Skylaki S, Menendez S, Kim SI, Johnsson A, Linnarsson S, Woltjen K, Chambers I, Kaji K.

Stem Cell Reports. 2015 Sep 8;5(3):350-64. doi: 10.1016/j.stemcr.2015.07.007. Epub 2015 Aug 13.

37.

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).

Casadevall D, Gimeno J, Clavé S, Taus Á, Pijuan L, Arumí M, Lorenzo M, Menéndez S, Cañadas I, Albanell J, Serrano S, Espinet B, Salido M, Arriola E.

Oncotarget. 2015 Jun 30;6(18):16215-26.

38.

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.

Rincón R, Cristóbal I, Zazo S, Arpí O, Menéndez S, Manso R, Lluch A, Eroles P, Rovira A, Albanell J, García-Foncillas J, Madoz-Gúrpide J, Rojo F.

Oncotarget. 2015 Feb 28;6(6):4299-314.

39.

The addition of a protease inhibitor increases the risk of infections in patients with hepatitis C-related cirrhosis.

Londoño MC, Perelló C, Cabezas J, Cañete N, Lens S, Mariño Z, Gambato M, Rodríguez R, Menéndez S, Carrión JA, Crespo J, Calleja JL, Forns X.

J Hepatol. 2015 Feb;62(2):311-6. doi: 10.1016/j.jhep.2014.09.025. Epub 2014 Oct 2.

PMID:
25281861
40.

Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.

García-Parra J, Dalmases A, Morancho B, Arpí O, Menendez S, Sabbaghi M, Zazo S, Chamizo C, Madoz J, Eroles P, Servitja S, Tusquets I, Yelamos J, Lluch A, Arribas J, Rojo F, Rovira A, Albanell J.

Eur J Cancer. 2014 Oct;50(15):2725-34. doi: 10.1016/j.ejca.2014.07.004. Epub 2014 Aug 12.

PMID:
25128455
41.

High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients.

Cañadas I, Taus A, González I, Villanueva X, Gimeno J, Pijuan L, Dómine M, Sánchez-Font A, Vollmer I, Menéndez S, Arpí O, Mojal S, Rojo F, Rovira A, Albanell J, Arriola E.

Oncotarget. 2014 Jul 30;5(14):5246-56.

42.

Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis.

Casellas F, Vicens DG, Menéndez SR, Oliver NA.

J Crohns Colitis. 2014 Sep;8(9):1097-107. doi: 10.1016/j.crohns.2014.02.013. Epub 2014 Mar 5.

PMID:
24613279
43.

Computerized physician order entry-based system to prevent HBV reactivation in patients treated with biologic agents: the PRESCRIB project.

Sampedro B, Hernández-López C, Ferrandiz JR, Illaro A, Fábrega E, Cuadrado A, Iruzubieta P, Menéndez S, Cabezas J, Crespo J.

Hepatology. 2014 Jul;60(1):106-13. doi: 10.1002/hep.27103. Epub 2014 May 28.

PMID:
24585503
44.

Gene expression profiling in true interval breast cancer reveals overactivation of the mTOR signaling pathway.

Rojo F, Domingo L, Sala M, Zazo S, Chamizo C, Menendez S, Arpi O, Corominas JM, Bragado R, Servitja S, Tusquets I, Nonell L, Macià F, Martínez J, Rovira A, Albanell J, Castells X.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):288-99. doi: 10.1158/1055-9965.EPI-13-0761. Epub 2013 Dec 17.

45.

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.

Dalmases A, González I, Menendez S, Arpí O, Corominas JM, Servitja S, Tusquets I, Chamizo C, Rincón R, Espinosa L, Bigas A, Eroles P, Furriol J, Lluch A, Rovira A, Albanell J, Rojo F.

Oncotarget. 2014 Jan 15;5(1):196-210.

46.

Cell death proteins as markers of early postmortem interval.

C Zapico S, Menéndez ST, Núñez P.

Cell Mol Life Sci. 2014 Aug;71(15):2957-62. doi: 10.1007/s00018-013-1531-x. Epub 2013 Dec 3.

PMID:
24297385
47.

Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.

Cañadas I, Rojo F, Taus Á, Arpí O, Arumí-Uría M, Pijuan L, Menéndez S, Zazo S, Dómine M, Salido M, Mojal S, García de Herreros A, Rovira A, Albanell J, Arriola E.

Clin Cancer Res. 2014 Feb 15;20(4):938-50. doi: 10.1158/1078-0432.CCR-13-1330. Epub 2013 Nov 27.

48.

The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a.

Sparks A, Dayal S, Das J, Robertson P, Menendez S, Saville MK.

Oncogene. 2014 Sep 18;33(38):4685-96. doi: 10.1038/onc.2013.413. Epub 2013 Oct 14.

49.

Wild boar tuberculosis in Iberian Atlantic Spain: a different picture from Mediterranean habitats.

Muñoz-Mendoza M, Marreros N, Boadella M, Gortázar C, Menéndez S, de Juan L, Bezos J, Romero B, Copano MF, Amado J, Sáez JL, Mourelo J, Balseiro A.

BMC Vet Res. 2013 Sep 8;9:176. doi: 10.1186/1746-6148-9-176.

50.

Ozone oxidative postconditioning ameliorates joint damage and decreases pro-inflammatory cytokine levels and oxidative stress in PG/PS-induced arthritis in rats.

Vaillant JD, Fraga A, Díaz MT, Mallok A, Viebahn-Hänsler R, Fahmy Z, Barberá A, Delgado L, Menéndez S, Fernández OS.

Eur J Pharmacol. 2013 Aug 15;714(1-3):318-24. doi: 10.1016/j.ejphar.2013.07.034. Epub 2013 Jul 31.

PMID:
23911887

Supplemental Content

Loading ...
Support Center